BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 23303213)

  • 1. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
    Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of omentin and chemerin in metabolic syndrome and tumor diseases.
    Szydło B; Kiczmer P; Świętochowska E; Ostrowska Z
    Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):844-9. PubMed ID: 27516571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
    Nway NC; Sitticharoon C; Chatree S; Maikaew P
    Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women.
    Faramarzi M; Banitalebi E; Nori S; Farzin S; Taghavian Z
    J Sports Med Phys Fitness; 2016 Apr; 56(4):476-82. PubMed ID: 25651894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of omentin gene expression and glucose homeostasis of visceral and subcutaneous adipose tissues in non-diabetic adults.
    Daneshafrooz A; Yuzbashian E; Zarkesh M; Asghari G; Mirmiran P; Hedayati M; Abooshahab R; Fanaei SM; Khalaj A
    Mol Biol Rep; 2022 Jan; 49(1):163-169. PubMed ID: 34739694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue dysfunction in nascent metabolic syndrome.
    Bremer AA; Jialal I
    J Obes; 2013; 2013():393192. PubMed ID: 23653857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY.
    Kadoglou NP; Tahmatzidis DK; Giannakoulas C; Kapelouzou A; Gkontopoulos A; Parissis J; Lampropoulos S; Kottas G
    J Cardiovasc Med (Hagerstown); 2015 May; 16(5):341-6. PubMed ID: 25022935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus].
    Pan BL; Ma RM
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1231-1236. PubMed ID: 27687656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis.
    Gurung P; Moussa K; Adams-Huet B; Devaraj S; Jialal I
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E504-E509. PubMed ID: 30620639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS).
    Martínez-García MÁ; Montes-Nieto R; Fernández-Durán E; Insenser M; Luque-Ramírez M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E388-96. PubMed ID: 23337724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum chemerin is associated with inflammatory and metabolic parameters-results of a population-based study.
    Zylla S; Pietzner M; Kühn JP; Völzke H; Dörr M; Nauck M; Friedrich N
    Obesity (Silver Spring); 2017 Feb; 25(2):468-475. PubMed ID: 28071854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children.
    Ciresi A; Pizzolanti G; Leotta M; Guarnotta V; Teresi G; Giordano C
    J Endocrinol Invest; 2016 Sep; 39(9):1023-30. PubMed ID: 27126309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue dysregulation in patients with metabolic syndrome.
    Bremer AA; Devaraj S; Afify A; Jialal I
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1782-8. PubMed ID: 21865369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of selected adipokines with metabolic syndrome and cardio-metabolic risk factors in young males.
    Ouerghi N; Ben Fradj MK; Talbi E; Bezrati I; Feki M; Bouassida A
    Cytokine; 2020 Sep; 133():155170. PubMed ID: 32554156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.
    Tsiotra PC; Halvatsiotis P; Patsouras K; Maratou E; Salamalekis G; Raptis SA; Dimitriadis G; Boutati E
    Peptides; 2018 Mar; 101():157-166. PubMed ID: 29337272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease.
    El-Mesallamy HO; El-Derany MO; Hamdy NM
    Diabet Med; 2011 Oct; 28(10):1194-200. PubMed ID: 21668495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.
    Guvenc Y; Var A; Goker A; Kuscu NK
    J Int Med Res; 2016 Aug; 44(4):796-805. PubMed ID: 27225862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between circulating serum omentin-1 levels and nascent metabolic syndrome in patients with hypertension.
    Cetin Sanlialp S; Nar G; Nar R
    J Investig Med; 2022 Mar; 70(3):780-785. PubMed ID: 34857627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls.
    Nurten E; Vogel M; Michael Kapellen T; Richter S; Garten A; Penke M; Schuster S; Körner A; Kiess W; Kratzsch J
    J Pediatr Endocrinol Metab; 2018 Sep; 31(9):959-969. PubMed ID: 30179852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.